🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the therapeutic effects and safety of odanacatib o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01552122
To determine the effect of denosumab treatment compared with placebo over 1...
Status
Completed
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT00043186
Treatments Being Tested
Osteoporosis is a common disease defined as a decrease in bone mass and str...
Status
Completed
Location
Siriraj Hospital
Start Date
2014-04
Trial ID
NCT02371252
Treatments Being Tested
This study will provide objective evidence for the efficiency and safety of...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2023-01-01
Trial ID
NCT05645289
Treatments Being Tested
This study will evaluate participant-reported preference for either ibandro...
Status
Completed
Location
Multiple Locations
Start Date
2004-03
Trial ID
NCT02598440
Treatments Being Tested
The purpose of this study is to determine if treatment is effective in prev...
Status
Completed
Location
Research Site
Start Date
2012-05-04
Trial ID
NCT01631214
Treatments Being Tested
The aim of the study is to assess the relative antiresorptive properties of...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-01
Trial ID
NCT01750086
Treatments Being Tested
This study will investigate participant satisfaction (including compliance,...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT02604836
Treatments Being Tested
This study investigates the use of blood tests known as Bone Turnover Marke...
Status
Completed
Location
Northwest General Hospital
Start Date
2025-10-01
Trial ID
NCT07242612
Treatments Being Tested
This is a randomized, double-blind, double-dummy, positive-controlled phase...
Status
Unknown
Location
Peking University First Hospital
Start Date
2022-06-15
Trial ID
NCT05397938
Treatments Being Tested